Exercise: How it can help both during and after cancer treatment
Liz Davis - Cancer Exercise Specialist, London, UK
Exercise: How it can help both during and after cancer treatment ( Liz Davis - Cancer Exercise Specialist, London, UK )
24 May 2019
Ovarian cancer: a current update
Prof Christina Fotopoulou - Queen Charlotte's and Chelsea Hospital, London, UK
Ovarian cancer: a current update ( Prof Christina Fotopoulou - Queen Charlotte's and Chelsea Hospital, London, UK )
24 May 2019
Ovarian cancer: Current treatments and latest advances
Dr Susana Banerjee - The Royal Marsden NHS Foundation Trust, London, UK
Ovarian cancer: Current treatments and latest advances ( Dr Susana Banerjee - The Royal Marsden NHS Foundation Trust, London, UK )
24 May 2019
The value of surgery in ovarian cancer
Prof Christina Fotopoulou - Queen Charlotte's and Chelsea Hospital, London, UK
The value of surgery in ovarian cancer ( Prof Christina Fotopoulou - Queen Charlotte's and Chelsea Hospital, London, UK )
24 May 2019
Latest in ovarian cancer treatment
Dr Susana Banerjee - The Royal Marsden NHS Foundation Trust, London, UK
Latest in ovarian cancer treatment ( Dr Susana Banerjee - The Royal Marsden NHS Foundation Trust, London, UK )
24 May 2019
Bladder Problems following ovarian cancer treatment
Ellie Stewart - Guy’s and St Thomas NHS Foundation Trust, London, UK
Bladder Problems following ovarian cancer treatment ( Ellie Stewart - Guy’s and St Thomas NHS Foundation Trust, London, UK )
24 May 2019
Treating ovarian cancer patients with PARP inhibitors
Kimberly Halla - Arizona Oncology Associates PC, Scottsdale, USA
Treating ovarian cancer patients with PARP inhibitors ( Kimberly Halla - Arizona Oncology Associates PC, Scottsdale, USA )
8 May 2019
PARP inhibitors and their side effects in solid tumour therapy
Paula Anastasia - David Geffen School of Medicine at UCLA Los Angeles, USA
PARP inhibitors and their side effects in solid tumour therapy ( Paula Anastasia - David Geffen School of Medicine at UCLA Los Angeles, USA )
8 May 2019
Providing safe care to hereditary cancer patients and families
Suzanne Mahon - Saint Louis University, Missouri, USA
Providing safe care to hereditary cancer patients and families ( Suzanne Mahon - Saint Louis University, Missouri, USA )
8 May 2019
Treating ovarian cancers with PARP inhibitors
Lisa Marie Juden - Dana-Farber Cancer Institute, Boston, MA
Treating ovarian cancers with PARP inhibitors ( Lisa Marie Juden -  Dana-Farber Cancer Institute, Boston, MA )
8 May 2019
Evaluation of M7824, a bifunctional fusion protein targeting TGF-β and PD-L1, in...
Dr James Gulley - National Cancer Institute, Bethesda, USA
Evaluation of M7824, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with HPV-associated malignancies ( Dr James Gulley - National Cancer Institute, Bethesda, USA )
15 Apr 2019
Using T cell engineering plus triple checkpoint blockade to enhance the efficacy...
Dr Kristin Anderson - Fred Hutchinson Cancer Research Center, Seattle, USA
Using T cell engineering plus triple checkpoint blockade to enhance the efficacy of adoptive immunotherapy in ovarian cancer ( Dr Kristin Anderson - Fred Hutchinson Cancer Research Center, Seattle, USA )
15 Apr 2019